Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

3 Biotech Quick Picks to Invest $5,000 This WeekPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
3 Biotech Quick Picks to Invest $5,000 This Week

Building a balanced portfolio of healthcare stocks requires investing in safer and more mature companies as well as riskier upstarts to drive long-term growth. Between Gilead Sciences (NASDAQ: GILD)

Zynga to Spend $1.8 Billion to Acquire Peak
Zynga to Spend $1.8 Billion to Acquire Peak

Zynga (NASDAQ: ZNGA) is spending $1.8 billion to acquire Peak, the Turkish mobile gaming company behind Toon Blast and Toy Blast, for $1.8 billion. 

In a press release announcing the acquisition

Why You Need North American Railroads
Why You Need North American Railroads

In this episode of Industry Focus: Energy, Nick Sciple chats with Fool.com contributor Lou Whiteman about the railroad industry. They provide an overview of the railroad industry, the major players

How the Financial Solvency of Employers Affects a 401(k)
How the Financial Solvency of Employers Affects a 401(k)

In this episode of Motley Fool Answers, Alison Southwick, Motley Fool personal finance expert Robert Brokamp, and Fool.com contributor Dan Caplinger answer listeners' questions about backdoor Roth

Gilead Reports Positive Late-Stage Study Results for Remdesivir in Patients With Moderate COVID-19Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Gilead Reports Positive Late-Stage Study Results for Remdesivir in Patients With Moderate COVID-19

On Monday, Gilead Sciences (NASDAQ: GILD) announced results from a phase 3 clinical trial evaluating remdesivir in treating hospitalized patients with moderate cases of COVID-19. The company stated

2 Best Biotech Stocks to Buy Right NowPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
2 Best Biotech Stocks to Buy Right Now

When it comes to biotech stocks, the recent focus has been on companies working on coronavirus treatments or prevention. While it's fine to jump on that bandwagon, there are other biotech investment

Is This Chinese E-Sports Stock Still Worth Buying?
Is This Chinese E-Sports Stock Still Worth Buying?

DouYu International (NASDAQ: DOYU), one of the top video game and live streaming platforms in China, went public nearly a year ago at $11.50 per share. However, DouYu didn't dazzle investors as much

Is Ulta Beauty Stock Headed Back Down to $230?Photo, wide shot, wide-angle lens,  Clothing manufacturer, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/4c710447-f68a-47bc-a682-c2d83e801596.png
Is Ulta Beauty Stock Headed Back Down to $230?

Ulta Beauty (NASDAQ: ULTA) has attracted another conflicted Wall Street pro. An analyst at Loop Capital this week boosted his price target on the retailer's stock while keeping his rating at a hold

Low-Price Retailers Post High GrowthPhoto, wide shot, wide-angle lens,  Fashion store, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.theapi.app/temp/4103ce22-87d6-4bef-ba44-0baf5ab280bb.png
Low-Price Retailers Post High Growth

In this episode of MarketFoolery, Chris Hill chats with Fool.com contributor Dan Kline about the latest news from the markets. They look at the retail space and how retail businesses are serving

Netflix Makes a Smart Move in Its Quest for 100 Million Subscribers
Netflix Makes a Smart Move in Its Quest for 100 Million Subscribers

The novel coronavirus pandemic has been a source of economic despair across the globe as people have been forced to remain at home to contain the spread. But entertainment seekers looking for

Only 23% of Older Workers Are Considering This Smart Social Security Strategy
Only 23% of Older Workers Are Considering This Smart Social Security Strategy

Millions of retirees depend on Social Security benefits to make ends meet during their senior years. The average Social Security recipient receives just over $1,500 per month in benefits, and nearly

Okta Stock Could Be Cruising for a Bruising in June
Okta Stock Could Be Cruising for a Bruising in June

Everybody's loving Okta (NASDAQ: OKTA) these days. The shares have more than doubled since bottoming out in mid-March, hitting another all-time high last week. The identity management platform

3 Reasons AT&T Should Sell DirecTV
3 Reasons AT&T Should Sell DirecTV

Five years ago, AT&T (NYSE: T) bought DirecTV for $49 billion to become the largest pay TV provider in the U.S. and the world. At the time, AT&T believed it could bundle DirecTV's satellite TV

Coty Names New CEO as Part of Deal With KKR
Coty Names New CEO as Part of Deal With KKR

In another chapter of the ongoing saga of businesses struggling amid the COVID-19 pandemic, Coty (NYSE: COTY) announced today that Peter Harf, the company's chairman, will take over as CEO to attend

Beyond Meat Products to Be Sold at Pizza Hut, KFC, Taco Bell in China
Beyond Meat Products to Be Sold at Pizza Hut, KFC, Taco Bell in China

Beyond Meat (NASDAQ: BYND) is about to make a big leap across the Pacific Ocean. The company announced that it is dramatically increasing its presence in China, and will introduce its plant-based

Moderna Starts a Phase 2 Clinical Trial for Its COVID-19 VaccinePhoto, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Moderna Starts a Phase 2 Clinical Trial for Its COVID-19 Vaccine

Moderna (NASDAQ: MRNA) has enrolled the first participants in a phase 2 clinical trial testing mRNA-1273, its vaccine against the novel coronavirus that causes COVID-19.

The move puts the biotech

The Move 1 in 4 Americans Is Making About Retirement
The Move 1 in 4 Americans Is Making About Retirement

If people were worried about having enough money for retirement before the pandemic, it's nothing to what they're feeling now. The "great lockdown" has deprived millions of Americans of their normal

3 Things Social Security Beneficiaries Need to Know About Plans for a Second COVID-19 Stimulus Check
3 Things Social Security Beneficiaries Need to Know About Plans for a Second COVID-19 Stimulus Check

COVID-19 has had a big impact on the finances of most Americans, including retirees receiving Social Security. The Coronavirus Aid, Relief, and Economic Security Act (CARES Act) provided payments of

Macao Casino Revenue Plunges Another 93% in MayPhoto, wide shot, wide-angle lens,  Hotel, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/d14bb504-852b-4d13-a69a-8cec9d4eb799.png
Macao Casino Revenue Plunges Another 93% in May

Casinos operating in Macao saw revenue plunge another 93% in May as China maintained travel restrictions to the region due to the coronavirus pandemic. However, it was better than the 95% drop

Why You Shouldn't Buy Papa John's Stock Despite Massive Sales Increases
Why You Shouldn't Buy Papa John's Stock Despite Massive Sales Increases

Papa John's International (NASDAQ: PZZA) has become one of the more notable success stories of the COVID-19 pandemic. With competition from sit-down restaurants temporarily sidelined, the pizza

2 of the Easiest, Most Affordable Ways to Invest in the Stock Market
2 of the Easiest, Most Affordable Ways to Invest in the Stock Market

Investing in the stock market is one of the best ways to build wealth, but it can also be intimidating -- especially for beginners.

Approximately 41% of Americans say they're too nervous to invest

Ulta Beauty Reports a Rough Quarter But Shows Signs of Life
Ulta Beauty Reports a Rough Quarter But Shows Signs of Life

Traditional retailers of all kinds have been hit hard by the COVID-19 outbreak, and investors are starting to get a picture of how bad the damage is. Of course, e-commerce companies have been

3 Dates for Disney Investors to Circle in June
3 Dates for Disney Investors to Circle in June

May wasn't too bad for Disney (NYSE: DIS) shareholders. The stock moved 8.5% higher for the month, nearly doubling the general market's return. A mixed quarterly report, the reopening of Shanghai